Senolytic Drugs: Clearing Out Zombie Cells to Reverse Aging
Discover how revolutionary drugs target 'zombie cells' that accumulate with age, potentially reversing aging and extending healthspan.
20 articles
Discover how revolutionary drugs target 'zombie cells' that accumulate with age, potentially reversing aging and extending healthspan.
Explore the molecular mechanisms of cellular senescence and how p16/p21 pathways drive SASP production, plus cutting-edge senolytic drug targets.
Master the cutting-edge molecular targets, clinical trial data, and emerging therapeutic strategies aimed at reversing ECM aging — from senolytic combinations to biomaterial scaffolds and epigenetic reprogramming.
A rigorous mechanistic deep-dive into how hydrogen sulfide orchestrates epigenetic reprogramming, proteostasis, and inter-organ signaling — and what the latest pharmacological evidence reveals about targeting H₂S for human longevity.
Master the molecular mechanisms linking energy sensing to cellular cleanup through AMPK-TFEB signaling cascades and lysosomal biogenesis pathways.
Dissect the precise molecular architecture governing SASP regulation — from chromatin remodeling and cGAS-STING activation to extracellular vesicle-mediated spread and next-generation senolytic strategies.
Master the full systems-level view of polyamine biology — from biosynthetic flux control and post-translational modifications to clinical trial design and emerging therapeutic strategies.
A deep mechanistic exploration of PI3K isoform biology, PTEN regulation, and the emerging pharmacology of PI3K-AKT-FOXO signaling as a therapeutic lever for healthspan extension.
A deep mechanistic examination of mitophagy's molecular circuitry — from ubiquitin chain topology to mitochondrial-nuclear crosstalk — and the emerging therapeutic strategies targeting this pathway to slow aging.
Dive into the molecular architecture of age-related membrane deterioration — from phospholipase regulation and lipid raft proteomics to ferroptosis thresholds, ceramide signaling networks, and emerging lipid-targeted interventions.
Discover how compounds like resveratrol and metformin can trigger the same life-extending pathways as caloric restriction without reducing food intake.
Discover how simply eating less — or taking strategic breaks from eating — can activate your body's built-in longevity switches, backed by decades of research across species.
Go beyond the basics and explore the precise biochemical mechanisms by which hydrogen sulfide extends healthspan — from persulfidation to mitochondrial electron transport.
A mechanistic deep-dive into the molecular architecture of redox signaling — from cysteine oxidation chemistry to therapeutic targeting of NRF2, NADPH oxidases, and mitochondrial ROS in the context of aging.
Dive deep into partial reprogramming, niche remodeling, senolytics, and cutting-edge clinical therapies — the molecular toolkit for reversing stem cell aging.
Go beneath the surface of senescent cell biology to understand the precise molecular machinery driving the SASP — and how these signals corrupt neighboring cells, fuel inflammation, and accelerate tissue aging.
A deep mechanistic exploration of the signaling networks governing thymic involution and the most promising therapeutic strategies — from FOXN1 gene therapy to senolytics — entering clinical translation.
Go beneath the surface of the PI3K pathway to understand how phospholipid messengers, kinase cascades, and feedback loops shape the balance between growth and longevity.
Go beyond the basics and explore the precise signaling pathways, protein machinery, and regulatory networks that determine which mitochondria live and which get recycled — and why this matters for aging.
A deep mechanistic exploration of mTOR complex architecture, allosteric regulation, and the cutting-edge therapeutic strategies targeting this pathway for healthspan extension.